142 related articles for article (PubMed ID: 18388402)
21. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
[TBL] [Abstract][Full Text] [Related]
22. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency.
Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
Bone; 2011 May; 48(5):1015-21. PubMed ID: 21352961
[TBL] [Abstract][Full Text] [Related]
23. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
24. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort.
Mohan G; Perilli E; Parkinson IH; Humphries JM; Fazzalari NL; Kuliwaba JS
Osteoarthritis Cartilage; 2013 Oct; 21(10):1595-604. PubMed ID: 23827368
[TBL] [Abstract][Full Text] [Related]
25. Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
Akahoshi S; Sakai A; Arita S; Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Nakamura T
J Bone Miner Metab; 2005; 23(5):341-50. PubMed ID: 16133683
[TBL] [Abstract][Full Text] [Related]
26. The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
Yamamoto M; Markatos A; Seedor JG; Masarachia P; Gentile M; Rodan GA; Balena R
Calcif Tissue Int; 1993 Oct; 53(4):278-82. PubMed ID: 8275357
[TBL] [Abstract][Full Text] [Related]
27. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
Huuskonen J; Arnala I; Olkkonen H; Alhava E
Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
[TBL] [Abstract][Full Text] [Related]
28. Combined treatment with a traditional Chinese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) and alendronate improves bone microstructure in ovariectomized rats.
Chen H; Wu M; Kubo KY
J Ethnopharmacol; 2012 Jun; 142(1):80-5. PubMed ID: 22543171
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of growth hormone and alpha calcidol on trabecular and cortical bones in hypophysectomized rats.
Chaudhry AA; Castro-Magana M; Aloia JF; Yeh JK
Pediatr Res; 2009 Apr; 65(4):403-8. PubMed ID: 19092717
[TBL] [Abstract][Full Text] [Related]
30. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
[TBL] [Abstract][Full Text] [Related]
31. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
32. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized young rats.
Iwamoto J; Takeda T; Yeh JK; Ichimura S; Toyama Y
Maturitas; 2003 Jan; 44(1):19-27. PubMed ID: 12568732
[TBL] [Abstract][Full Text] [Related]
33. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
Correa CB; Camargos GV; Chatterjee M; Mesquita MF; Del Bel Cury AA; Naert I; Duyck J; Vandamme K
Osteoporos Int; 2017 Apr; 28(4):1287-1293. PubMed ID: 27921147
[TBL] [Abstract][Full Text] [Related]
34. Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
Shomali T; Rezaian M; Rassouli A; Asadi F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):46-50. PubMed ID: 19302435
[TBL] [Abstract][Full Text] [Related]
35. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
36. Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats.
Liu XQ; Chen HY; Tian XY; Setterberg RB; Li M; Jee WS
J Bone Miner Metab; 2008; 26(5):425-35. PubMed ID: 18758900
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
[TBL] [Abstract][Full Text] [Related]
38. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
[TBL] [Abstract][Full Text] [Related]
39. S-ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats.
Zeng QQ; Jee WS; Ke HZ; Wechter WJ
Bone Miner; 1993 Jun; 21(3):203-18. PubMed ID: 8400920
[TBL] [Abstract][Full Text] [Related]
40. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
Exp Anim; 2006 Jul; 55(4):349-55. PubMed ID: 16880682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
